Aug 27 |
Eli Lilly Launches New, Cheaper Version of Obesity Drug Zepbound Amid High Demand
|
Aug 27 |
Pfizer launches DTC service for migraine, COVID drugs
|
Aug 27 |
Eli Lilly Slashes Zepbound Weight Loss Vial Prices By Up To 50% To Boost Access
|
Aug 27 |
Pfizer, joining Lilly, enters the direct-to-consumer market with a telehealth and prescription platform
|
Aug 27 |
Lilly rolls out Zepbound vials at a discount price
|
Aug 27 |
Eli Lilly Zepbound prices slashed by 50% for lowest doses
|
Aug 27 |
Lilly releases ZepboundĀ® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity
|
Aug 27 |
Eli Lilly to Sell New Zepbound Option for About Half Price of Injection Pens
|
Aug 27 |
The Zacks Analyst Blog Eli Lilly, Chevron, Abbott and Bridger Aerospace
|
Aug 27 |
Zacks.com featured highlights include Norwegian Cruise Line, Eli Lilly, The Progressive and Fortinet
|